12th International Bordetella Symposium

第十二届国际博德特氏菌研讨会

• 批准号: 9805872
• 负责人: Eric T Harvill
• 金额: $ 3万
• 依托单位: UNIVERSITY OF GEORGIA
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-12-01 至 2019-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9805872
• 关键词: 12th; International; Bordetella; Symposium

Project Summary/Abstract: Pertussis or whooping cough was once considered a disease of the past but it is now one of the least controlled vaccine preventable diseases. Pertussis is primarily caused by the Gram negative pathogen, Bordetella pertussis, but several other Bordetellae cause similar diseases in humans as well as animals. The reemergence of pertussis correlates with the transition to the acellular pertussis vaccines (DTaP and Tdap) in the early 1990s. Since the 1960’s the Bordetella research community has organized international meetings which provide an opportunity for trainees, physicians, scientists, epidemiologists, public health officials, and vaccine manufacturers to assemble and focus on the problems together to move forward. The International Symposium occurs on a three-four year cycle. The International Bordetella Symposium has served to build collaborations, exchange ideas, establish priorities, and facilitate training opportunities for the next generation of scientists. At the 11th symposium there were 50 oral presentations and 110 posters presented by 196 attendees from 20 total countries. The 12th Symposium will be held at Brussels University and will be hosted by Prof. Françoise Mascart and Dr. Camille Locht. The organizing committee made up of 11 internationally known scientists who will directly participate in the planning and administration of meeting. It is expected the 12th symposium will host 300 participants. The meeting agenda includes: Bordetella biology, genomics, evolution, epidemiology, pathogenesis and virulence factors, animal models of disease and transmission, immune responses to infection and immunization, vaccine design, as well as other important topics. While there are numerous meetings that discuss bacterial pathogens, this is the only symposium that exclusively focuses on Bordetella. In order to support development of the next generation of scientists, this application is requesting funds to defray the costs of the 12th International Bordetella Symposium, in Brussels in April 2019.

项目摘要/摘要：百日咳或百日咳曾经被认为是一种疾病 百日咳是过去最不受控制的疫苗可预防疾病之一。 主要由革兰氏阴性病原体百日咳博德特氏菌引起，但还有其他几种 博德特氏菌在人类和动物中引起类似的疾病。 百日咳与向无细胞百日咳疫苗（DTaP 和 Tdap）的过渡相关 自 20 世纪 60 年代初以来，Bordetella 研究界就组织起来了。 国际会议为学员、医生、科学家、 流行病学家、公共卫生官员和疫苗制造商聚集在一起并重点关注 国际研讨会以三四方式共同解决问题。 国际博德特氏菌研讨会致力于建立合作， 交流想法、确定优先事项并为下一代提供培训机会 第 11 届研讨会有 50 场口头报告和 110 幅墙报。 来自 20 个国家的 196 名与会者提出了第 12 届研讨会的报告。 布鲁塞尔大学，由 Françoise Mascart 教授和 Camille Locht 博士主持。 组委会由11位国际知名科学家组成，直接参与 预计第十二届研讨会将接待300人。 会议议程包括：博德特氏菌生物学、基因组学、进化论、 流行病学、发病机制和毒力因素、疾病和传播的动物模型、 对感染和免疫的免疫反应、疫苗设计以及其他重要的 虽然有许多会议讨论细菌病原体，但这是唯一的。 专门关注博德特氏菌的研讨会，以支持下一步的发展。 一代科学家，该申请正在请求资金来支付费用 第十二届国际博德特氏菌研讨会，2019 年 4 月在布鲁塞尔举行。